U.S. rule on Chinese biotech deals scrutiny announced

AI justification

[Auto-resolved by learned corrector: learned-map — A=MINT/B=NEUTRAL -> MINT (human chose this in 93% of 255 past reviews)] Rule adds scrutiny to prevent biosecurity/human‑rights risks, protecting rights despite collaboration costs. | The proposed rule introduces a trade-off between safeguarding against potential human rights abuses and biosecurity risks versus undermining global health collaboration and scientific equity. While the intent to prevent unethical practices is laudable, the broad app